Clinical Trial

Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

Study acronym: CRAFT-CTCA
Recruiting
View on ClinicalTrials.gov →
Summary
Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation. Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes. This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function. The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-22; most recent amendment 2026-02-12.
Trial Details
NCT Number NCT06234410
Lead Sponsor University of Edinburgh
Collaborators: Chief Scientist Office of the Scottish Government, University of Glasgow, NHS Lothian, NHS Greater Glasgow and Clyde
Conditions Cardiovascular Diseases, Kidney Transplant; Complications
Enrollment 332 participants
Start Date 2024-01-24
Primary Completion 2032-01 (estimated)
Study Completion 2032-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-13